FDA Legislation in the 110th Congress : A Guide to S. 1082 and H.R. 2900.
Presents comparative overview of provisions of S. 1082, the Food and Drug Administration Revitalization Act of 2007, and H.R. 2900, the Food and Drug Administration Amendments Act of 2007, both to reauthorize existing FDA programs and expand FDA authority to ensure safety of prescription drugs, medi...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2007.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Presents comparative overview of provisions of S. 1082, the Food and Drug Administration Revitalization Act of 2007, and H.R. 2900, the Food and Drug Administration Amendments Act of 2007, both to reauthorize existing FDA programs and expand FDA authority to ensure safety of prescription drugs, medical devices, and biologics. Provides background on FDA relevant to S.1082 and H.R. 2900. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |